Print
Health Care

New Lab In Wisconsin Expands Wilmington Based PPD's Testing Capabilities

By Jenny Callison, posted Mar 29, 2018
PPD this week announced a new analytical laboratory at its existing facility in Middleton, Wisconsin. The lab will expand PPD’s testing capacity, according to an announcement Wednesday by the Wilmington-based company.

The 32,000-square-foot Good Manufacturing Practices (GMP) lab “supplements the company’s existing biologics capacity and was constructed specifically for the stability and quality control testing of large molecule drug products,” the news release stated.

Planned for a workforce of more than 100, the new lab contains specialized areas designed for particular types of assays and scientific instrumentation specific to biologics, according to the release.

Biological products, or biologics, include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues and recombinant therapeutic proteins.

According to the Federal Drug Administration, biologics – as distinguished from chemical synthetics – are products isolated from a variety of natural sources. 

“The expansion of our biologics testing, which nearly doubles our analytical testing capacity, enables us to meet the ever-growing needs of our clients for GMP testing of large molecule products,” Jon Denissen, senior vice president of the PPD Laboratories bioanalytical and GMP labs, said in the release. “From early clinical development through commercial release testing, clients rely on our industry-leading capabilities in large molecule product testing. With deep expertise that spans the full spectrum of protein-based and gene-based biologics, we support many of the most cutting-edge immuno-oncology, gene therapy and cell therapy agents being developed or marketed today.”

PPD is also renovating its existing cell lab at the Middleton campus to double the lab’s capacity for GMP cell-based assays, the release stated, adding, “The expanded 5,900-square-foot laboratory will support a total of 70 cellular and molecular biology scientists upon its completion in mid-2018.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
Johndevaneycapefearclinic300x300

Cape Fear Clinic Pharmacy

John Devaney - Cape Fear Clinic
Img 1576c1

Is Diversification Oversold?

Eddie Nowell - South Atlantic Capital Management Group
Img 0801

The 3 Most Important Questions Before You Retire

Brett Tushingham - Tushingham Wealth Strategies

Trending News

Wheelz Pizza Aims To Revolutionize Pizza Delivery

Jessica Maurer - May 22, 2019

Cameron Apartment Project Rezoning Request To Come Before Planning Board

Jenny Callison - May 23, 2019

JuSea To Offer Healthy Options On Carolina Beach Boardwalk

Jessica Maurer - May 22, 2019

New Tenants Announced For Leland Retail Center

Cece Nunn - May 23, 2019

Home Sales In April Slumped 12% In Wilmington Area; Decline Blamed On Inventory

Cece Nunn - May 22, 2019

In The Current Issue

Trattoria On Market St. Savors Popularity

The eggplant Parmesan is so popular at Rosalie’s Trattoria, the restaurant can’t keep the vegetable in stock, said owner Al Cervini....


The Economy Of Outdoor Offerings

Outdoor venues provide spaces to let the good times roll, but is the money rolling in too? It seems to be. Despite last year’s hurricane, ti...


Curiosity Sparks Engineer's Career

On a day in Wilmington about four decades ago, elementary school student Ron Sparks asked a pharmacist a question, then watched as the blood...

Book On Business

The 2019 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2019 WilmingtonBiz Expo Keynote Lunch - CEO, nCino, Pierre Naude`
Transporting the Future - Power Breakfast 3.12.2019
Health Care Heroes 2018